Hyman, Phelps & McNamara, P.C. is pleased to announce that Adrienne Lenz will be speaking on Deciphering New and Proposed Regulatory Guidances For Medical Devices and Diagnostics at the Q1 Productions 4th Annual Life Science Regulatory Intelligence Virtual Event being held January 24-25, 2022. The foundation of the regulatory intelligence and strategy is to remain abreast of current regulatory and legislative guidelines. The magnitude of guidance documents affecting a product throughout its lifecycle makes this a continual challenge for regulatory teams. This session will highlight current guidance documents that are of key importance to device and diagnostic manufacturers and regulatory intelligence executives. This virtual event brings together global intelligence, strategy, policy and legal experts to share best practices on challenges faced by regulatory teams.
FDA Law Blog readers are offered a discount of 15% off the registration price. The case-sensitive discount code is Q1HPM15. You can access conference information and register for the event here.